schizophrenia – News and resources

Nov 22 2024

Uncategorized

Viewing extreme states of mind through the psychosis superspectrum. – Psychology Today

by Clinical Editor

No Comments

Viewing extreme states of mind through the psychosis superspectrum. Psychology Today

Nov 22 2024

Uncategorized

Cannabis disrupts brain activity in young adults prone to psychosis

by Clinical Editor

No Comments

Young adults at risk of psychosis show reduced brain connectivity, a deficit that cannabis use appears to worsen, a new study has found. The breakthrough paves the way for psychosis...

Nov 21 2024

Uncategorized

New schizophrenia drug could treat Alzheimer’s disease

by Clinical Editor

No Comments

Since a schizophrenia drug, the first in decades with an innovative mechanism of action, gained US regulatory approval in September, some researchers have proclaimed a new era for psychiatric medicine...

Nov 21 2024

Uncategorized

Bipolar Disorder and Schizophrenia—On the Same Spectrum?

by Clinical Editor

No Comments

While the hallmarks of psychosis include qualities like hallucinations and unusual beliefs, the pathways to psychosis may bear an array of diagnoses, from severe mood disorders to schizophrenia and …

Nov 20 2024

Uncategorized

Unique brain activity discovered when schizophrenia patients deal with misinformation

by Clinical Editor

No Comments

Schizophrenia, a complex mental health disorder, profoundly impacts a patient’s cognitive abilities. Now, a new study finds that a schizophrenic’s brain activity displays unique signs when they’re …

Nov 20 2024

Uncategorized

Jordan Neely had severe schizophrenia, expert testifies at NYC subway chokehold trial

by Clinical Editor

No Comments

A psychiatric expert testifying in Daniel Penny’s defense said Jordan Neely had one of the most severe histories of paranoid schizophrenia he has ever reviewed.

Nov 19 2024

Uncategorized

Monument Therapeutics Announces Appointment of Dr Stephen Brannan, Dr Jeff Baker and Dr Mark Treherne to its Advisory Board to Guide Schizophrenia Program – Yahoo Finance

by Clinical Editor

No Comments

Monument Therapeutics Announces Appointment of Dr Stephen Brannan, Dr Jeff Baker and Dr Mark Treherne to its Advisory Board to Guide Schizophrenia Program Yahoo Finance

Nov 19 2024

Uncategorized

Multiple sclerosis drug may help with poor working memory

by Clinical Editor

No Comments

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health...

Nov 18 2024

Uncategorized